Proud moment as retired miners gather at 'the Geich' in Moodiesburn to display new branch banner
Retired miners got together to proudly display the new banner for their branch in North Lanarkshire.
Moodiesburn and District Retired Miners' Branch gathered at Auchengeich Memorial Garden recently to celebrate the new banner, which was produced by ex-miners and their families with a development grant from the Museums Galleries Scotland's Community Catalyst Fund as part of their Delivering Change Programme.
Funded by The National Lottery Heritage Fund, Esmée Fairbairn Foundation and the Scottish Government, the programme supports museums and galleries across Scotland to make changes to help all people access culture, recognising that museums have played a part in excluding the experiences and histories of many of Scotland's people and communities.
Northern Corridor Community Volunteers (NCCV) applied to be part of the programme which supports community organisations with lived experience of systemic exclusion to work in partnership with museums.
Working with ex-miners and their families, their goal is to have the voice and lived experience of mining communities - particularly those who lived through the 1980s, the strike and the pit closures - reflected in heritage offerings.
The project is working with the retired miners and local charity Cardowan Community Meadow and hopes to partner with local museums for further joint working over the next 18 months.
Claire Williams, NCCV funding officer, said: 'So far the programme has enabled us to bring local groups together to look at the current heritage offerings and think about the changes we want to see, this development phase has enabled a much needed banners project, giving the retired miners a banner they can be proud of, and working towards a replacement banner for Cardowan Colliery as theirs was sadly destroyed in a fire.
'The story of the creation of the memorial garden, the men behind it and their efforts in holding an annual memorial service, which is so important to the community locally, and the continued fight for worker protections, is one which deserves recognition, and we hope the next steps in the project will see that become a reality.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
25 minutes ago
- Yahoo
GoviEx secures ASX listing through reverse takeover deal with Tombador
GoviEx Uranium has agreed to a reverse takeover deal with Tombador Iron, paving the way for its entry onto the Australian Securities Exchange (ASX). Tombador is an ASX-listed shell with A$10.4m ($6.7m) in cash after selling its iron-ore business. It will acquire all GoviEx Class A shares via a court-approved process. The combined entity will be renamed Atomic Eagle and listed on the ASX. Post-transaction, GoviEx shareholders will own around 75% of Atomic Eagle, with Tombador shareholders holding the remaining 25%. A concurrent A$5–10m financing will increase the combined company's cash to A$19.4–24.4m. Atomic Eagle will focus on exploration and project development in Zambia, particularly the Muntanga Project. It will also target the exploration potential of the Karoo sandstones in Zambia. The combined company will have a tighter capital structure, reducing the number of GoviEx ordinary shares from more than one billion to approximately 345 million, after the transaction is completed. This is expected to result in a 'more efficient float' and lower share price volatility, offering more flexibility for future capital raises. Closing conditions include regulatory approvals from the ASX and TSX Venture Exchange, with completion expected in early November 2025. Matador Capital joins as a cornerstone investor, with founder Grant Davey set to be a strategic advisor to the board. GoviEx chief executive (CEO) Daniel Major will retain his position as CEO of the combined company and a new board with experienced industry professionals will be established, chaired by Govind Friedland, executive chairman of GoviEx. Friedland said: "This is a transformational transaction for GoviEx: it brings an Australian public listing, a new capital structure, a refreshed board, new substantial shareholders, a cornerstone investor with recent uranium development experience and a strengthened balance sheet. 'Our combined company, to be named Atomic Eagle Ltd, will lead the development of the Muntanga Project, situated in one of the largest and most under explored sandstone hosted uranium basins in the world, with considerable exploration potential. We are excited to move forward with unlocking its full potential." GoviEx's Board, advised by Stifel Canada, recommends shareholders vote in favour of the transaction, which is deemed 'fair' from a financial standpoint. "GoviEx secures ASX listing through reverse takeover deal with Tombador" was originally created and published by Mining Technology, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Yahoo
25 minutes ago
- Yahoo
Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies
Walgreens Boots Alliance, Inc. (NASDAQ:WBA) shares edged slightly higher on Tuesday. The firm's specialty pharmacy arm announced a significant expansion of its drug distribution network. The company revealed that Walgreens Specialty Pharmacy has broadened its limited distribution drug (LDD) portfolio to cover 265 therapies, strengthening its role as one of the most extensive specialty pharmacy networks in the are highly regulated medicines distributed through selected specialty pharmacies, often involving complex regimens, high costs, or special handling requirements. Unlike pharmacies linked to pharmacy benefit managers, Walgreens Specialty Pharmacy operates independently, which allows it to work flexibly with insurers, pharmaceutical manufacturers, healthcare providers, and other partners. This structure makes it possible to expand its collaborations without being restricted by direct PBM ties. 'As the limited distribution drug network continues to grow, our specialty pharmacy teams across the country are equipped to support manufacturers in getting their medications to patients who need it most,' said Tracey James, RPh, chief operating officer of Walgreens Specialty Pharmacy. She emphasized that independence helps the company engage broadly across the healthcare system. Specialty medicine has become one of the fastest-growing healthcare sectors, with roughly three-quarters of newly developed drugs falling into this category. To address these challenges, Walgreens employs a nationwide team of pharmacists, nurses, patient advocates, and insurance experts dedicated to supporting patients with unique conditions and complex treatment needs. Among the therapies added in 2025 are Yeztugo (lenacapavir) from Gilead Sciences, Inc. (NASDAQ:GILD), which is the first FDA-approved twice-yearly preventive treatment for HIV; Nemluvio (nemolizumab) from Galderma (OTC:GALDY), targeting moderate-to-severe atopic dermatitis and prurigo nodularis; and Imkeldi (imatinib) from Shorla Oncology, a therapy for certain blood cancers and related diseases. According to Benzinga Pro, WBA stock has gained over 10% in the past year. Investors can gain exposure to the stock via Invesco S&P 500 Equal Weight Consumer Staples ETF (NYSE:RSPS). Price Action: WBA stock is trading higher by 0.21% to $12.03 at last check Tuesday. Read Next: Image via Shutterstock UNLOCKED: 5 NEW TRADES EVERY WEEK. Click now to get top trade ideas daily, plus unlimited access to cutting-edge tools and strategies to gain an edge in the markets. Get the latest stock analysis from Benzinga? This article Walgreens Grows Specialty Pharmacy Network To Meet Rising Demand For Complex Therapies originally appeared on © 2025 Benzinga does not provide investment advice. All rights reserved. Error while retrieving data Sign in to access your portfolio Error while retrieving data Error while retrieving data Error while retrieving data Error while retrieving data
Yahoo
25 minutes ago
- Yahoo
Skipton Business Finance names Michelle Wilson as COO
Skipton Business Finance (SBF) has confirmed the permanent appointment of Michelle Wilson as Chief Operating Officer after an eight-month stint as Interim COO. Wilson, who joined the lender as a Director last year, succeeds in the role she has held since stepping in to support SBF's growth drive. Wilson brings more than two decades of invoice finance expertise to her new post. She spent 23 years at Close Brothers Invoice Finance, 16 of them in senior operational leadership roles such as Head of Commercial Client Services and Head of Northern Operations, before moving to SBF. Since her arrival, she has been credited with sharpening operational performance and lifting client experience across the business. Wilson said she was 'delighted to be taking on the role on a permanent basis,' adding that she's witnessed 'first-hand the passion and commitment' of the SBF team. As part of the Skipton Group, SBF underwrites invoice finance facilities to UK SMEs with a combined turnover exceeding £2 billion. Chief Executive Greg Bell praised Wilson for injecting 'structure, energy and clarity' during her interim tenure, stating her appointment 'strengthens our senior team and positions us strongly for future growth.' "Skipton Business Finance names Michelle Wilson as COO" was originally created and published by Leasing Life, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
